A detailed history of Brewin Dolphin Wealth Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 5,400 shares of MRK stock, worth $535,518. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,400
Previous 5,452 0.95%
Holding current value
$535,518
Previous $447,000 10.07%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 14, 2022

SELL
$83.49 - $94.64 $4,341 - $4,921
-52 Reduced 0.95%
5,400 $492,000
Q1 2022

Nov 14, 2022

BUY
$73.51 - $82.4 $3,822 - $4,284
52 Added 0.96%
5,452 $447,000
Q4 2021

Nov 14, 2022

BUY
$72.28 - $90.54 $390,312 - $488,916
5,400 New
5,400 $414,000
Q2 2021

Nov 09, 2023

BUY
$70.31 - $77.77 $2,109 - $2,333
30 Added 0.5%
6,000 $467 Million
Q1 2021

Nov 09, 2023

SELL
$68.86 - $81.11 $2,065 - $2,433
-30 Reduced 0.5%
5,970 $460 Million
Q2 2020

Nov 09, 2023

BUY
$70.42 - $80.13 $42,252 - $48,078
600 Added 11.11%
6,000 $464 Million
Q1 2020

Nov 09, 2023

BUY
$63.36 - $87.82 $1,900 - $2,634
30 Added 0.6%
5,024 $387 Million
Q2 2019

Nov 09, 2023

BUY
$69.84 - $81.59 $182,282 - $212,949
2,610 Added 109.48%
4,994 $419 Million
Q1 2019

Nov 09, 2023

SELL
$69.58 - $79.36 $209,853 - $239,349
-3,016 Reduced 55.85%
2,384 $198 Million
Q3 2018

Nov 09, 2023

SELL
$57.69 - $67.84 $173,993 - $204,605
-3,016 Reduced 55.85%
2,384 $169 Million
Q4 2017

Nov 09, 2023

BUY
$51.62 - $61.64 $23,796 - $28,416
461 Added 23.97%
2,384 $134 Million
Q3 2017

Nov 09, 2023

SELL
$58.67 - $63.13 $203,995 - $219,503
-3,477
1,923 $123 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.